Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

February 2015 - FRMC

Department

News Connection
02/18/2015
Diabetes is a major health problem with the incidence rate continuing to rise in the United States. 
Diabetes is a major health problem with the incidence rate continuing to rise in the United States. 
Diabetes is a major health...
02/18/2015
First Report Managed Care
Conference Insider
02/17/2015

Kerri Fitzgerald

Kerri Fitzgerald
Rheumatoid arthritis is largely associated with significant morbidity, mortality, and overall costs.
Rheumatoid arthritis is largely associated with significant morbidity, mortality, and overall costs.
Rheumatoid arthritis is largely...
02/17/2015
First Report Managed Care
Conference Insider
02/17/2015

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
According to the 2014 Surgeon General’s report on the consequences of smoking, secondhand tobacco smoke causes about 34,000 premature deaths from heart disease each year in the United States among nonsmokers.
According to the 2014 Surgeon General’s report on the consequences of smoking, secondhand tobacco smoke causes about 34,000 premature deaths from heart disease each year in the United States among nonsmokers.
According to the 2014 Surgeon...
02/17/2015
First Report Managed Care
Department
02/18/2015
Psoriasis is a common chronic skin disease characterized by cutaneous inflammation and epidermal hyperproliferation.
Psoriasis is a common chronic skin disease characterized by cutaneous inflammation and epidermal hyperproliferation.
Psoriasis is a common chronic...
02/18/2015
First Report Managed Care
02/17/2015

Kerri Fitzgerald

Kerri Fitzgerald
Tumor necrosis factor inhibitors are often used for the treatment of rheumatoid arthritis; but, they are associated with side effects, and are costly medications.
Tumor necrosis factor inhibitors are often used for the treatment of rheumatoid arthritis; but, they are associated with side effects, and are costly medications.
Tumor necrosis factor inhibitors...
02/17/2015
First Report Managed Care
02/17/2015
Eileen Koutnik-Fotopoulos
Eileen Koutnik-Fotopoulos
Labor, delivery, and the postpartum period are a time of increased arrhythmia and congestive heart failure incidence.
Labor, delivery, and the postpartum period are a time of increased arrhythmia and congestive heart failure incidence.
Labor, delivery, and the...
02/17/2015
First Report Managed Care
02/17/2015
Eileen Koutnik-Fotopoulos
Eileen Koutnik-Fotopoulos
New research found that young women with stable coronary heart disease are more likely than men of the same age to develop reduced blood flow to the heart if they are under emotional stress but not physical stress.
New research found that young women with stable coronary heart disease are more likely than men of the same age to develop reduced blood flow to the heart if they are under emotional stress but not physical stress.
New research found that young...
02/17/2015
First Report Managed Care
02/17/2015
Kerri Fitzgerald
Kerri Fitzgerald
As the US population continues to age, questions arise regarding Medicare costs and implications for the federal budget.
As the US population continues to age, questions arise regarding Medicare costs and implications for the federal budget.
As the US population continues...
02/17/2015
First Report Managed Care

News

News
02/17/2015
Kerri Fitzgerald
Kerri Fitzgerald
Psoriatic arthritis (PsA) is associated with progressive pain, fatigue, disability, structural damage, and reduced health-related quality of life. Interluekin-17A antagonists are developing as a potential treatment option for PsA.
Psoriatic arthritis (PsA) is associated with progressive pain, fatigue, disability, structural damage, and reduced health-related quality of life. Interluekin-17A antagonists are developing as a potential treatment option for PsA.
Psoriatic arthritis (PsA) is...
02/17/2015
First Report Managed Care
News
02/17/2015

Kerri Fitzgerald

Kerri Fitzgerald
Boston—The results of a recent study indicated that apremilast demonstrated clinically meaningful improvements in psoriatic arthritis (PsA) disease activity measures that were sustained with continual treatment for 52 weeks. Improvements were...
Boston—The results of a recent study indicated that apremilast demonstrated clinically meaningful improvements in psoriatic arthritis (PsA) disease activity measures that were sustained with continual treatment for 52 weeks. Improvements were...
Boston—The results of a recent...
02/17/2015
First Report Managed Care

Advertisement

Advertisement

Advertisement